Logo image of BPRN

PRINCETON BANCORP INC (BPRN) Stock Fundamental Analysis

NASDAQ:BPRN - Nasdaq - US74179A1079 - Common Stock - Currency: USD

30.19  -0.3 (-0.98%)

After market: 30.19 0 (0%)

Fundamental Rating

4

Overall BPRN gets a fundamental rating of 4 out of 10. We evaluated BPRN against 393 industry peers in the Banks industry. While BPRN seems to be doing ok healthwise, there are quite some concerns on its profitability. BPRN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BPRN was profitable.
BPRN had a positive operating cash flow in the past year.
BPRN had positive earnings in each of the past 5 years.
BPRN had a positive operating cash flow in each of the past 5 years.
BPRN Yearly Net Income VS EBIT VS OCF VS FCFBPRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1.2 Ratios

BPRN has a worse Return On Assets (0.49%) than 75.57% of its industry peers.
BPRN has a Return On Equity of 4.22%. This is amonst the worse of the industry: BPRN underperforms 80.15% of its industry peers.
Industry RankSector Rank
ROA 0.49%
ROE 4.22%
ROIC N/A
ROA(3y)1.15%
ROA(5y)1.13%
ROE(3y)8.9%
ROE(5y)8.74%
ROIC(3y)N/A
ROIC(5y)N/A
BPRN Yearly ROA, ROE, ROICBPRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 14.42%, BPRN is doing worse than 76.84% of the companies in the same industry.
BPRN's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for BPRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 14.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-25.7%
PM growth 5Y-9.52%
GM growth 3YN/A
GM growth 5YN/A
BPRN Yearly Profit, Operating, Gross MarginsBPRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

BPRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BPRN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BPRN has more shares outstanding
BPRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BPRN Yearly Shares OutstandingBPRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
BPRN Yearly Total Debt VS Total AssetsBPRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

BPRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC9.02%
BPRN Yearly LT Debt VS Equity VS FCFBPRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BPRN Yearly Current Assets VS Current LiabilitesBPRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

The earnings per share for BPRN have decreased strongly by -35.53% in the last year.
Measured over the past years, BPRN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.24% on average per year.
The Revenue has grown by 12.23% in the past year. This is quite good.
The Revenue has been growing by 10.74% on average over the past years. This is quite good.
EPS 1Y (TTM)-35.53%
EPS 3Y-4.66%
EPS 5Y14.24%
EPS Q2Q%-87.5%
Revenue 1Y (TTM)12.23%
Revenue growth 3Y3.55%
Revenue growth 5Y10.74%
Sales Q2Q%17.8%

3.2 Future

The Earnings Per Share is expected to grow by 17.28% on average over the next years. This is quite good.
The Revenue is expected to grow by 15.03% on average over the next years. This is quite good.
EPS Next Y-10.36%
EPS Next 2Y17.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.58%
Revenue Next 2Y15.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BPRN Yearly Revenue VS EstimatesBPRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
BPRN Yearly EPS VS EstimatesBPRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.42, which indicates a correct valuation of BPRN.
Based on the Price/Earnings ratio, BPRN is valued a bit more expensive than the industry average as 61.83% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.25, BPRN is valued rather cheaply.
A Price/Forward Earnings ratio of 7.67 indicates a rather cheap valuation of BPRN.
BPRN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BPRN is cheaper than 82.44% of the companies in the same industry.
BPRN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.42
Fwd PE 7.67
BPRN Price Earnings VS Forward Price EarningsBPRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BPRN is valued a bit more expensive than the industry average as 75.83% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 22.02
EV/EBITDA N/A
BPRN Per share dataBPRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

BPRN's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.94
EPS Next 2Y17.28%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.82%, BPRN has a reasonable but not impressive dividend return.
BPRN's Dividend Yield is a higher than the industry average which is at 3.33.
BPRN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

The dividend of BPRN is nicely growing with an annual growth rate of 43.51%!
BPRN has been paying a dividend for over 5 years, so it has already some track record.
BPRN has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)43.51%
Div Incr Years0
Div Non Decr Years6
BPRN Yearly Dividends per shareBPRN Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BPRN pays out 69.18% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BPRN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP69.18%
EPS Next 2Y17.28%
EPS Next 3YN/A
BPRN Yearly Income VS Free CF VS DividendBPRN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BPRN Dividend Payout.BPRN Dividend Payout, showing the Payout Ratio.BPRN Dividend Payout.PayoutRetained Earnings

PRINCETON BANCORP INC

NASDAQ:BPRN (7/31/2025, 4:30:01 PM)

After market: 30.19 0 (0%)

30.19

-0.3 (-0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)N/A N/A
Inst Owners44.61%
Inst Owner Change0.26%
Ins Owners24.78%
Ins Owner Change7.51%
Market Cap209.22M
Analysts80
Price Target33.92 (12.36%)
Short Float %0.82%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly Dividend1.15
Dividend Growth(5Y)43.51%
DP69.18%
Div Incr Years0
Div Non Decr Years6
Ex-Date05-06 2025-05-06 (0.3)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.85%
Min EPS beat(2)-14.17%
Max EPS beat(2)-1.53%
EPS beat(4)2
Avg EPS beat(4)35.05%
Min EPS beat(4)-14.17%
Max EPS beat(4)142.22%
EPS beat(8)6
Avg EPS beat(8)61.01%
EPS beat(12)10
Avg EPS beat(12)41.7%
EPS beat(16)13
Avg EPS beat(16)33.19%
Revenue beat(2)0
Avg Revenue beat(2)-4.42%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.6%
Revenue beat(4)0
Avg Revenue beat(4)-3.37%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.6%
Revenue beat(8)0
Avg Revenue beat(8)-4.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.04%
Revenue beat(16)7
Avg Revenue beat(16)1.86%
PT rev (1m)0%
PT rev (3m)-2.21%
EPS NQ rev (1m)-103.64%
EPS NQ rev (3m)-103.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.76%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 13.42
Fwd PE 7.67
P/S 2.68
P/FCF 22.02
P/OCF 18.76
P/B 0.78
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)2.25
EY7.45%
EPS(NY)3.93
Fwd EY13.03%
FCF(TTM)1.37
FCFY4.54%
OCF(TTM)1.61
OCFY5.33%
SpS11.28
BVpS38.53
TBVpS35.96
PEG (NY)N/A
PEG (5Y)0.94
Profitability
Industry RankSector Rank
ROA 0.49%
ROE 4.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.42%
GM N/A
FCFM 12.15%
ROA(3y)1.15%
ROA(5y)1.13%
ROE(3y)8.9%
ROE(5y)8.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-25.7%
PM growth 5Y-9.52%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 68.18%
Cap/Sales 2.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 84.26%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)61.04%
Cap/Depr(5y)81.63%
Cap/Sales(3y)1.65%
Cap/Sales(5y)2.5%
Profit Quality(3y)100.08%
Profit Quality(5y)92.19%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.53%
EPS 3Y-4.66%
EPS 5Y14.24%
EPS Q2Q%-87.5%
EPS Next Y-10.36%
EPS Next 2Y17.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.23%
Revenue growth 3Y3.55%
Revenue growth 5Y10.74%
Sales Q2Q%17.8%
Revenue Next Year14.58%
Revenue Next 2Y15.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.36%
FCF growth 3Y4.09%
FCF growth 5Y0.19%
OCF growth 1Y-57.97%
OCF growth 3Y4.52%
OCF growth 5Y-2.89%